Ken Griffin
NXTC icon

Ken Griffin’s NextCure NXTC Stock Holding History

Ken Griffin’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Buy
+15,292
New +$187K ﹤0.01% 11623
2025
Q3 		– Sell
-4,904
Closed -$27.1K – 13704
2025
Q2 		$27.1K Sell
4,904
-2,650
-35% -$14.2K ﹤0.01% 12023
2025
Q1 		$43.5K Buy
7,554
+997
+15% +$8.79K ﹤0.01% 12445
2024
Q4 		$60.7K Buy
6,557
+1,894
+41% +$27.9K ﹤0.01% 12171
2024
Q3 		$76.7K Sell
4,663
-19,425
-81% -$357K ﹤0.01% 11459
2024
Q2 		$460K Buy
24,088
+3,632
+18% +$70.6K ﹤0.01% 8226
2024
Q1 		$547K Sell
20,456
-10,865
-35% -$187K ﹤0.01% 8180
2023
Q4 		$428K Sell
31,321
-5,230
-14% -$75.8K ﹤0.01% 8432
2023
Q3 		$566K Buy
36,551
+3,779
+12% +$72.1K ﹤0.01% 7798
2023
Q2 		$708K Sell
32,772
-7,215
-18% -$142K ﹤0.01% 7175
2023
Q1 		$710K Sell
39,987
-3,527
-8% -$67.9K ﹤0.01% 7535
2022
Q4 		$736K Buy
43,514
+4,006
+10% +$92.2K ﹤0.01% 7426
2022
Q3 		$1.3M Buy
39,508
+6,727
+21% +$343K ﹤0.01% 6434
2022
Q2 		$1.85M Buy
32,781
+282
+0.9% +$14.7K ﹤0.01% 5693
2022
Q1 		$1.9M Sell
32,499
-304
-0.9% -$19K ﹤0.01% 6209
2021
Q4 		$2.36M Sell
32,803
-257
-0.8% -$21.5K ﹤0.01% 5864
2021
Q3 		$2.67M Sell
33,060
-26,242
-44% -$2.3M ﹤0.01% 5638
2021
Q2 		$5.71M Sell
59,302
-29,066
-33% -$2.97M ﹤0.01% 4149
2021
Q1 		$10.6M Sell
88,368
-1,119
-1% -$162K ﹤0.01% 2881
2020
Q4 		$11.7M Sell
89,487
-268
-0.3% -$34.6K ﹤0.01% 2436
2020
Q3 		$9.48M Buy
89,755
+85,192
+1,867% +$10.5M ﹤0.01% 2349
2020
Q2 		$1.17M Sell
4,563
-2,397
-34% -$913K ﹤0.01% 5538
2020
Q1 		$3.1M Sell
6,960
-59,516
-90% -$31.8M ﹤0.01% 3412
2019
Q4 		$44.9M Sell
66,476
-11,987
-15% -$6.01M 0.02% 837
2019
Q3 		$29M Sell
78,463
-12,686
-14% -$4.13M 0.01% 1152
2019
Q2 		$16.4M Buy
+91,149
New +$18.9M 0.01% 1620

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Ken Griffin's NXTC Position: Q1 2026 in Review

Ken Griffin opened a new position in NextCure (NXTC) in Q1 2026: 15,292 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #11623 among its holdings. This is a return to the name: Ken Griffin previously reported a position in NXTC as recently as Q2 2025.

Ken Griffin first reported a position in NXTC in Q2 2019 and has held it in 26 quarters since. The position peaked at $44.9M in Q4 2019. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Ken Griffin held 15,292 shares of NextCure worth $161K as of Q1 2026.
  • NextCure was a new Ken Griffin position in Q1 2026.
  • NextCure made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #11623 holding.
  • Ken Griffin first reported a position in NextCure in Q2 2019 and has held it in 26 quarters since.
  • Ken Griffin's NextCure position peaked at $44.9M in Q4 2019.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.